Allworth Financial’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $141K | Buy |
1,353
+1,060
| +362% | +$111K | ﹤0.01% | 1339 |
|
2025
Q1 | $30.9K | Buy |
293
+6
| +2% | +$632 | ﹤0.01% | 1802 |
|
2024
Q4 | $29.4K | Hold |
287
| – | – | ﹤0.01% | 1857 |
|
2024
Q3 | $25.8K | Sell |
287
-25
| -8% | -$2.25K | ﹤0.01% | 1746 |
|
2024
Q2 | $26.5K | Sell |
312
-10
| -3% | -$849 | ﹤0.01% | 1703 |
|
2024
Q1 | $25.7K | Buy |
322
+305
| +1,794% | +$24.3K | ﹤0.01% | 1624 |
|
2023
Q4 | $1.35K | Sell |
17
-52
| -75% | -$4.14K | ﹤0.01% | 2844 |
|
2023
Q3 | $4.82K | Buy |
69
+31
| +82% | +$2.17K | ﹤0.01% | 2124 |
|
2023
Q2 | $2.73K | Buy |
38
+20
| +111% | +$1.44K | ﹤0.01% | 2361 |
|
2023
Q1 | $1.11K | Hold |
18
| – | – | ﹤0.01% | 2632 |
|
2022
Q4 | $1.39K | Hold |
18
| – | – | ﹤0.01% | 2362 |
|
2022
Q3 | $1K | Buy |
18
+13
| +260% | +$722 | ﹤0.01% | 2307 |
|
2022
Q2 | $0 | Buy |
+5
| New | – | ﹤0.01% | 2389 |
|